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checks. The authors reported the demographic and clinical characteristics of the patients divided into two groups, those with HD and those without. There were 86 patients with HD, of which 66% were men. The mean age was 69.7 (+/-11.8) years). There were 44 patients without H, of which 59% were men. The mean age was 68.7 (+/-12.5) years. Power calculations do not appear to have been performed.
Study design
This was a prospective within-group comparison study, because the same group of patients underwent all diagnostic strategies during the first visit. The diagnostic criteria used for each technique were described. In case of abnormal test results, two or more of the authors (experienced clinical cardiologists) who were unaware of the patient's clinical information gave their opinion on whether the patient had or did not have HD and classified them accordingly. The study was carried out in a teaching hospital and two community hospitals. The length of follow-up was not stated. No loss to follow-up appears to have occurred.
Analysis of effectiveness
All of the patients in the initial study sample were accounted for in the effectiveness study. The health outcomes used in the study were the sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV). Comparability of the study groups was not relevant as a single group of patients was used.
Effectiveness results
With BNP, the sensitivity was 0.90, the specificity 0.98, the accuracy 0.92, the PPV 0.99 and the NPV 0.83.
With ECG, the sensitivity was 0.78, the specificity 0.66, the accuracy 0.74, the PPV 0.82 and the NPV 0.60.
With CR, the sensitivity was 0.66, the specificity 0.89, the accuracy 0.74, the PPV 0.92 and the NPV 0.57.
With ECHO, the sensitivity was 0.91, the specificity 1, the accuracy 0.94, the PPV 1 and the NPV 0.85.
All of the values estimated with ECG and CR were significantly lower than those reported with BNP, with the exception of the specificity with CR. There was a significant difference between the values observed with ECHO and BNP.
The authors also reported the positive and negative rates for each test in patients classified according to their diagnosis.
Clinical conclusions
The effectiveness analysis showed that the BNP and ECHO strategies had the best diagnostic characteristics in comparison with ECG and CR, in untreated patients with symptoms suggestive of HD.
Measure of benefits used in the economic analysis
The summary benefit measures used in the economic analyses were the five outcome measures estimated in the effectiveness study, namely sensitivity, specificity, accuracy, PPV and NPV.
Direct costs
Discounting was not relevant because the costs were incurred in a short time period. The unit costs were reported separately from the quantities of resources used. The health services included in the economic evaluation were BNP, ECG, CR and ECHO (including the extra cost of using the Doppler technique). The cost/resource boundary of the study was that of the Japanese NHI system. Resource consumption was estimated using data derived from the sample of patients included in the effectiveness study (from November 1997 to April 2001 . The unit costs were based on NHI reimbursement rates at April 2001, which appears to have been the price year.
